Nrx pharmaceuticals provides business update and reports second quarter 2022 results focusing on reactivation & advancement of its psychiatry franchise

Company to host conference call and webcast august 15, 2022, at 8:30am et radnor, pa. , aug. 15, 2022  /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), ("nrx pharmaceuticals" or the "company"), a clinical-stage biopharmaceutical company, today announced its financial results for the second quarter of 2022 and provided a business and clinical update.
NRXP Ratings Summary
NRXP Quant Ranking